British start-up Doccla raises € 41 million in Series B funding
Photo: Aids for patients from DOCCLA (Photo © Doccla)
More news
4. September 2024
London — The British start-up Doccla wants to go international with its telemedicine system and has raised almost 41 million euros.
— Lakestar is leading the Series B round, with Elaia and General Catalyst, Speedinvest and Bertelsmann as well as several existing investors also participating.
The funding comes two years after Doccla raised a $17 million Series A round.
— Lakestar is leading the Series B round, with Elaia and General Catalyst, Speedinvest and Bertelsmann as well as several existing investors also participating.
The funding comes two years after Doccla raised a $17 million Series A round.
Hospitals around the world regularly struggle with bed shortages — a problem that can be exacerbated in the event of a health crisis or other large-scale disaster.
The startup Doccla is using technology to solve this problem: It is developing “virtual bed” technology that allows doctors to remotely care for patients who have either been discharged early or, in some cases, never come to the hospital at all.
The startup Doccla is using technology to solve this problem: It is developing “virtual bed” technology that allows doctors to remotely care for patients who have either been discharged early or, in some cases, never come to the hospital at all.
Doccla has been providing doctors with technology to monitor their patients at home since 2019.
The company has completed the new financing round to ensure that its expansion into the D‑A‑CH region (Germany, Austria and Switzerland) and France is as successful as possible.
The company has completed the new financing round to ensure that its expansion into the D‑A‑CH region (Germany, Austria and Switzerland) and France is as successful as possible.
To date, Doccla has monitored over 4 million patient days, with a compliance rate of over 95%.
The company claims to enroll 1,000 new patients per month.
In the long term, Doccla is aiming for 100,000 new patients per month.
The company claims to enroll 1,000 new patients per month.
In the long term, Doccla is aiming for 100,000 new patients per month.
An initial pilot project is already underway in Germany Doccla enables patients to be discharged from hospital and receive continuous, high-quality care at home.
— According to a study funded by the NHS, regional NHS departments were able to reduce emergency room visits by 63 percent by using Doccla and at the same time achieve a 300 percent return on investment.
This probably also convinced those responsible at the Bad Reichenhall district clinic: they brought the system to Germany without further ado as part of a pilot project in February 2024, but are only using it for individual patients for the time being due to the healthcare system not yet being geared towards telemedicine.
— According to a study funded by the NHS, regional NHS departments were able to reduce emergency room visits by 63 percent by using Doccla and at the same time achieve a 300 percent return on investment.
This probably also convinced those responsible at the Bad Reichenhall district clinic: they brought the system to Germany without further ado as part of a pilot project in February 2024, but are only using it for individual patients for the time being due to the healthcare system not yet being geared towards telemedicine.